Michael Baum - Concepedia

Author

Michael Baum

University College London ORCID

Also Known As

Baum, M., Baum, Michael, Jessica Toole, M BAUM, M Baum, M, Baum, M. BAUM, M. Baum, M. S. Baum, MICHAEL BAUM

544

Publications

21.7K

Citations

H-Index

186

Concepts

All Affiliations

University College London Royal Marsden Hospital King's College Hospital The Royal Free Hospital Royal Marsden NHS Foundation Trust

About

Michael Baum is an author at University College London specializing in medicine, oncology, and breast cancer.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Health Sciences	14	18	856
2	Education	3	3	137
3	Engineering	1	1	16
4	Law	1	1	12
5	Management	1	1	29

Michael Baum

139

Publications

14.4K

Citations

H-Index

Page 1

	Year	Citations
Effect of anastrozole and tamoxifen as adjuvant treatment for early-stage breast cancer: 10-year analysis of the ATAC trial Jack Cuzick, Ivana Šestak, Michael Baum, The Lancet Oncology Breast OncologyOncologyAtac TrialPharmacologyAdjuvant Treatment	2010	1.7K
Risk-adapted targeted intraoperative radiotherapy versus whole-breast radiotherapy for breast cancer: 5-year results for local control and overall survival from the TARGIT-A randomised trial Jayant S. Vaidya, Frederik Wenz, Max Bulsara, The Lancet	2013	822
Targeted intraoperative radiotherapy versus whole breast radiotherapy for breast cancer (TARGIT-A trial): an international, prospective, randomised, non-inferiority phase 3 trial Jayant S. Vaidya, David Joseph, Jeffrey Tobias, The Lancet Surgical OncologyBreast OncologyRadiation TherapyTargit-a TrialMedicine	2010	756
Psychological outcomes of different treatment policies in women with early breast cancer outside a clinical trial. Lesley Fallowfield, Angela Hall, G. P. Maguire, BMJ	1990	750
First results from the International Breast Cancer Intervention Study (IBIS-I): a randomised prevention trial J Cuzick, JF Forbes, Rob Edwards, The Lancet Breast OncologyPreventive MedicineCancer ScreeningGlobal HealthMedicine	2002	742
Prediction of Risk of Distant Recurrence Using the 21-Gene Recurrence Score in Node-Negative and Node-Positive Postmenopausal Patients With Breast Cancer Treated With Anastrozole or Tamoxifen: A TransATAC Study Mitch Dowsett, Jack Cuzick, Christopher Wale, Journal of Clinical Oncology	2010	718
Hypertension as a Biomarker of Efficacy in Patients With Metastatic Renal Cell Carcinoma Treated With Sunitinib Brian I. Rini, D. P. Cohen, Dongrui R. Lu, JNCI Journal of the National Cancer Institute	2011	575
Induction of transforming growth factor beta 1 in human breast cancer in vivo following tamoxifen treatment. A Butta, KA MacLennan, K C Flanders, PubMed Breast OncologyTamoxifen TreatmentHuman GrowthPathologyHuman Breast Cancer	1992	343
Effects of breast conservation on psychological morbidity associated with diagnosis and treatment of early breast cancer. Lesley Fallowfield, Michael Baum, G. P. Maguire BMJ PsychotherapyPsychological Co-morbiditiesBreast OncologyPsychological MorbiditySurgery	1986	329
Anti-oestrogens induce the secretion of active transforming growth factor beta from human fetal fibroblasts AA Colletta, FV Howell, KE van Roozendaal, British Journal of Cancer Human Fetal FibroblastsAnti-oestrogens InduceDevelopmental BiologyGrowth HormoneHuman Growth	1990	318

Page 1